Driving reinvestment in R&D for antibiotics and advocating their responsible use

DRIVE-AB Conference 2016: Stimulating innovation, sustainable use and global access to antibiotics

Stimulating innovation, sustainable use and global access to antibiotics

2 June 2016
Amsterdam, The Netherlands

The consortium is organizing a high-level conference to bring together policy makers, regulatory and public health experts, and economists to identify and evaluate reward models that are feasible, practical and can be implemented globally. This conference is supported by the EU Presidency of the Netherlands.

This event is expected to stimulate a dialogue among international decision-makers on the implementation of R&D incentive policies which will help to inform DRIVE-AB final recommendations, which will be announced in 2017.

Aim of the Conference
DRIVE-AB will present the preliminary results of its research and seek feedback from stakeholders regarding feasibility and implementation of R&D incentive policies. G7 Health ministers also noted: Given the global nature of drug research, development and commercialization and the global challenge antimicrobial resistance poses, we call for greater interaction and synergies between research initiatives.

The conference also seeks to determine how on-going European and international initiatives  addressing antimicrobial resistance can complement each other, and to identify opportunities for DRIVE-AB to interact with other initiatives.

Please click here to view the conference report.

Please click here to view a conference summary.

Please click here to read the pre-conference report.

Please click here to view the 2 June conference programme.

Please click here to read a document containing more detailed information on the economic models that were discussed, DRIVE-AB’s preliminary findings regarding innovation incentives: Incentives to stimulate antibiotic innovation: The preliminary findings of DRIVE-AB.


LogoDutch Presidency 2016 Logo